These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38531339)

  • 21. Anti-metastatic treatment in colorectal cancer: targeting signaling pathways.
    Lemos C; Sack U; Schmid F; Juneja M; Stein U
    Curr Pharm Des; 2013; 19(5):841-63. PubMed ID: 22973955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithelial-mesenchymal transition‑associated microRNAs in colorectal cancer and drug-targeted therapies (Review).
    Jin D; Fang Y; Li Z; Chen Z; Xiang J
    Oncol Rep; 2015 Feb; 33(2):515-25. PubMed ID: 25435189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of integrins in colorectal cancer.
    Le Tourneau C; Faivre S; Raymond E
    Oncology (Williston Park); 2007 Aug; 21(9 Suppl 3):21-4. PubMed ID: 17927027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways.
    Kahlert UD; Mooney SM; Natsumeda M; Steiger HJ; Maciaczyk J
    Int J Cancer; 2017 Jan; 140(1):10-22. PubMed ID: 27389307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors.
    Bagnasco L; Piras D; Parodi S; Bauer I; Zoppoli G; Patrone F; Ballestrero A
    Curr Cancer Drug Targets; 2012 May; 12(4):303-15. PubMed ID: 22385510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The implications of colorectal cancer molecular biology in clinical practice.
    Kargozaran H; Kahlenberg M; Khatri VP
    Surg Oncol Clin N Am; 2008 Apr; 17(2):341-55, viii-ix. PubMed ID: 18375356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EDITORIAL: Molecularly targeted treatments for colorectal cancer: advances and limitations.
    Parodi S
    Curr Cancer Drug Targets; 2012 May; 12(4):301-2. PubMed ID: 22385508
    [No Abstract]   [Full Text] [Related]  

  • 28. Systemic treatment for metastatic colorectal cancer in the era of precision medicine.
    Sandhu J; Lavingia V; Fakih M
    J Surg Oncol; 2019 Apr; 119(5):564-582. PubMed ID: 30802315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy.
    Goblirsch M; Richtig G; Slaby O; Berindan-Neagoe I; Gerger A; Pichler M
    Pharmacogenomics; 2017 Jul; 18(10):1027-1038. PubMed ID: 28639472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precision medicine beyond medical oncology: using molecular analysis to guide treatments of colorectal neoplasia.
    Molloy MP; Engel A
    Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1179-1181. PubMed ID: 30791786
    [No Abstract]   [Full Text] [Related]  

  • 31. MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.
    Stiegelbauer V; Perakis S; Deutsch A; Ling H; Gerger A; Pichler M
    World J Gastroenterol; 2014 Sep; 20(33):11727-35. PubMed ID: 25206276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting Angiogenesis in Colorectal Cancer: Tyrosine Kinase Inhibitors.
    Kircher SM; Nimeiri HS; Benson AB
    Cancer J; 2016; 22(3):182-9. PubMed ID: 27341596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel antineoplastics targeting genetic changes in colorectal cancer.
    Joudeh J; Allen JE; Das A; Prabhu V; Farbaniec M; Adler J; El-Deiry WS
    Adv Exp Med Biol; 2013; 779():1-34. PubMed ID: 23288633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic consequences of molecular biology advances in oncology].
    Bauvet F; Awada A; Gil T; Hendlisz A
    Bull Cancer; 2009 Jan; 96(1):59-71. PubMed ID: 19211361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of angiogenesis inhibitors in the treatment of colorectal cancer].
    Bodoky G
    Magy Onkol; 2007; 51(2):139-44. PubMed ID: 17660870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting cancer stem cells as therapeutic approach in the treatment of colorectal cancer.
    Parizadeh SM; Jafarzadeh-Esfehani R; Hassanian SM; Parizadeh SMR; Vojdani S; Ghandehari M; Ghazaghi A; Khazaei M; Shahidsales S; Rezayi M; Asgharzadeh F; Ghayour-Mobarhan M; Ferns GA; Avan A
    Int J Biochem Cell Biol; 2019 May; 110():75-83. PubMed ID: 30818083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The challenge to optimize medical therapy for advanced colorectal cancer.
    Hubbard JM; Grothey A
    J Natl Cancer Inst; 2014 Feb; 106(2):djt442. PubMed ID: 24511110
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeted therapy in colorectal cancer: current status and future challenges.
    Koutras AK; Starakis I; Kyriakopoulou U; Katsaounis P; Nikolakopoulos A; Kalofonos HP
    Curr Med Chem; 2011; 18(11):1599-612. PubMed ID: 21428886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New generations of targeted therapies fighting the resistance in solid tumors.
    Barthélémy P; Aftimos P; Awada A
    Curr Opin Oncol; 2015 May; 27(3):243-9. PubMed ID: 25715325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting BRAF in metastatic colorectal cancer: Maximizing molecular approaches.
    Strickler JH; Wu C; Bekaii-Saab T
    Cancer Treat Rev; 2017 Nov; 60():109-119. PubMed ID: 28946014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.